Immediately administer after reconstitution. Must not be administered as an IV infusion. Observe caution in patients w/ insulinoma. Can cause acute hypertensive reaction in the presence of pheochromocytoma. Therapeutic indication: When patient has responded to treatment, oral carbohydrates should be given to restore liver glycogen to prevent relapse of hypoglycaemia. Little or no effect when patient has been fasting for a prolonged period, or is suffering from adrenal insufficiency, chronic hypoglycaemia or alcohol-induced hypoglycaemia. Cannot assist in transference of carbohydrate from much larger stores of glycogen present in the skeletal muscle. Patient should not drive or operate machinery after a severe hypoglycaemic event until stabilised. Latex-sensitive individuals. Diagnostic indication: May experience discomfort (reports of nausea, hypoglycaemia, & BP changes), in particular if fasting. After the end of a diagnostic procedure, oral carbohydrates should be given to patients who have been fasting, if compatible w/ the diagnostic procedure applied. May increase myocardial O
2 demand, BP, & pulse rate; monitor patients w/ cardiac disease. May cause short term hyperglycaemia in patients w/ DM when used as a diagnostic aid; monitor for changes in blood glucose levels during use. Observe caution in patients w/ glucagonoma. Driving a vehicle & operating machinery should be avoided until patient has had a meal w/ oral carbohydrates. Safety & efficacy for inhibition of GI motility in childn & adolescents have not been established.
Sign Out
